Omeros Corporation
General ticker "OMER" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $373.9M (TTM average)
Omeros Corporation follows the US Stock Market performance with the rate: 0.7%.
Estimated limits based on current volatility of 4.3%: low 9.77$, high 10.64$
Factors to consider:
- Total employees count: 198 (-6.2%) as of 2023
- Top business risk factors: Cumulative operating losses, Operational and conduct risks, Regulatory and compliance, Litigation risks, Liquidity and credit risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.20$, 13.00$]
- 2025-12-31 to 2026-12-31 estimated range: [3.99$, 10.21$]
Financial Metrics affecting the OMER estimates:
- Negative: with PPE of -3.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -25.61 <= 0.33
- Positive: Investing cash flow per share per price, % of 14.15 > -0.66
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -65.91 <= 18.93
- Positive: Inventory ratio change, % of 0 <= 0
Short-term OMER quotes
Long-term OMER plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $163.39MM | $164.53MM | $169.26MM |
| Operating Income | $-163.39MM | $-164.53MM | $-169.26MM |
| Non-Operating Income | $-18.64MM | $-10.39MM | $-13.37MM |
| Interest Expense | $22.70MM | $30.84MM | $24.68MM |
| R&D Expense | $112.72MM | $114.87MM | $119.52MM |
| Income(Loss) | $-182.03MM | $-174.92MM | $-182.63MM |
| Other Income(Loss) | $229.45MM | $57.11MM | $0.00MM |
| Profit(Loss)* | $276.86MM | $-60.71MM | $-156.81MM |
| Stockholders Equity | $85.68MM | $-24.98MM | $-182.61MM |
| Assets | $590.97MM | $378.27MM | $277.08MM |
| Operating Cash Flow | $-86.48MM | $74.73MM | $-148.80MM |
| Capital expenditure | $0.11MM | $0.43MM | $0.17MM |
| Investing Cash Flow | $-127.56MM | $27.45MM | $82.22MM |
| Financing Cash Flow | $124.25MM | $-106.08MM | $62.88MM |
| Earnings Per Share** | $4.41 | $-0.97 | $-2.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.